We showed that mRNA overexpression of LANCL2 or EGFR, and their concurrent overexpression were not significantly associated with OS and PFS of GBM patients (Table 1, Fig. 2I, Additional file 1: Figure S2A). Here, LANCL2 is linked to glioblastoma.